503A/503B compounding pharmacies

Compounded semaglutide

1.9

halfrx score

$129–$349/mo for the same molecule — and the reason it is cheap is the reason it is risky.

All-in, per month

$129–$349

checked 2026-09-13 — no maintenance-dose price

Medication: compounded
Form: injection
Price checked: 2026-09-13

RxNorm has no product code for this, because there is no approved product to identify; 1991302 for the ingredient. The codes the US National Library of Medicine assigns, so this page names one specific thing rather than a brand that could mean several.

Cheapest route to the molecule. Price is the entire argument for it. Where this range comes from: the sellers of this on halfrx, each read on its own page — Strut Health $129–$199, 2026-09-22; Medvi $149–$299, 2026-09-14; Zealthy $151, 2026-09-22; Shed $159–$349, 2026-09-22; Lemonaid Health $178, 2026-09-22; Eden $198, 2026-09-13; Noom Med $199–$299, 2026-09-22. Nobody sells it directly, so there is no page of its own to re-read.

What this page used to say

2026-09-11 — A drawback that no longer stood. Was: Supply can stop mid-titration. A court order or state action against your compounder ends your prescription with no notice — Mochi's affiliated pharmacy is under a Washington State Notice of Immediate Jeopardy. Now: Supply can stop mid-titration. A court order or state action against your compounder ends your prescription with no notice — in March 2025 Washington's Pharmacy Commission issued a limited stop-service order against Aequita, the Kirkland pharmacy that then supplied Mochi Health.
2026-09-11 — A point in its favor that no longer stood. Was: $99–$299/mo puts semaglutide within reach for people who would otherwise take nothing — the branded self-pay floor is $349. Now: $99–$299 a month puts semaglutide within reach for people who would otherwise take nothing; branded semaglutide costs $299 a month for the Wegovy pill and $349 for the pens once past the starting doses.
2026-09-10 — A price no page could confirm, ninety-two days old. Was: $149–$299, checked 2026-06-10. Now: $99–$299, checked 2026-08-19.

Every correction on this site, dated →

How this monthly figure is built

The range charged by the sellers of it on this site; nobody sells it under this name.

How much does Compounded semaglutide cost a month?

halfrx records Compounded semaglutide at $129–$349 a month all-in, taken from the sellers of it on this site — nobody sells it under this name — the oldest of those readings on 2026-09-13. What it costs once titrated is not published, which is a fact about the seller rather than a gap in the data. It carries 2 flags on this site: not FDA approved and supply risk. It scores 1.9 out of 10 on a published formula that is arithmetic over the facts on this page, not an editor's opinion. The medication is compounded rather than FDA approved: a copy made under the pharmacy-compounding exemption, which is a legal status and not a quality claim. The page rests on 3 cited sources, at least one of them a manufacturer, regulator or journal. Anything past 45 days without a re-check is marked stale here rather than quietly aging. Molecule: semaglutide.

What it has cost

Down $20 a month since 2026-06-10

Last corrected on 2026-09-11 — see what this page used to say, above.

No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price

Not FDA approvedCompounding legal riskSupply risk

What is good about Compounded semaglutide?

+$129–$349 a month puts semaglutide within reach for people who would otherwise take nothing; branded semaglutide costs $299 a month for the Wegovy pill and $349 for the pens once past the starting doses.[1]
+Often shipped in vials with flexible dosing, so a provider can titrate in smaller steps than the fixed branded pen doses allow.[1]

What are the downsides of Compounded semaglutide?

−Not FDA approved. The agency does not review compounded drugs for safety, efficacy or manufacturing quality — potency and sterility depend entirely on the individual pharmacy.[1]
−The FDA declared the semaglutide shortage resolved, which removed the legal basis for mass compounding of copies. Providers now rely on 'personalized dose' arguments that Novo Nordisk is actively litigating.[2]
−Supply can stop mid-titration. A court order or state action against your compounder ends your prescription with no notice — in March 2025 Washington's Pharmacy Commission issued a limited stop-service order against Aequita, the Kirkland pharmacy that then supplied Mochi Health.[3]
−Some products are semaglutide salts (sodium or acetate) rather than the base molecule studied in trials. The FDA has warned these are different substances.[1]

How this score is built

0.0/3.5Evidence — no weight-management trial figure recorded
0.0/3Approval — not FDA approved
0.9/2.5Cost — $349/mo at maintenance (top of the published range)
1.0/1Caveats — no penalties on file

The full formula →

Clinical evidence

Not FDA approved. Compounded drugs are not reviewed by the FDA for safety, efficacy or quality.

No pivotal trial. Efficacy is inferred from branded semaglutide, not demonstrated for the compounded product.

What happens if you stop semaglutide: no Compounded semaglutide trial stopped it on purpose, but Wegovy's label did, at a maintenance dose of 2.4 mg once weekly, or 1.7 mg. The group that came off gained 6.9% of body weight in 48 weeks →

What you can take instead of Compounded semaglutide, with each one's verified price →

What Compounded semaglutide costs without insurance, and every route to the same drug →

Which sellers supply this molecule, and what each charges: Strut Health semaglutide →

Sources

[1] GLP-1 Telehealth Price Report 2026secondary
[2] Compounded GLP-1 providers under active litigationsecondary
[3] Washington Pharmacy Quality Assurance Commission: Limited Stop Service issued to Aequita Pharmacy, 13 March 2025primary archived 2026-03-15

Compare Compounded semaglutide with

2 more comparisons

Information only, not medical advice. Prices and terms change; the date above is when we last verified this one.

The registers and documents behind this page

What this drug is approved for, and what a compounded version of it is not, come from these.

Compounding and the FDA: questions and answers — What a compounded drug is, and what the FDA does and does not review before it is sold.
Medications containing semaglutide marketed for type 2 diabetes or weight loss, FDA — The FDA's own notice on compounded semaglutide and what it has not evaluated.